List of Tables
Table 1. Global KRAS G12C Inhibitors Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global KRAS G12C Inhibitors Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global KRAS G12C Inhibitors Market Competitive Situation by Manufacturers in 2025
Table 4. Global KRAS G12C Inhibitors Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global KRAS G12C Inhibitors Sales Market Share by Manufacturers (2021–2026)
Table 6. Global KRAS G12C Inhibitors Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global KRAS G12C Inhibitors Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market KRAS G12C Inhibitors Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of KRAS G12C Inhibitors, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of KRAS G12C Inhibitors, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of KRAS G12C Inhibitors, Product Types and Applications
Table 12. Global Key Manufacturers of KRAS G12C Inhibitors, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global KRAS G12C Inhibitors Companies by Tier (Tier 1, Tier 2, Tier 3), based on KRAS G12C Inhibitors Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global KRAS G12C Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global KRAS G12C Inhibitors Sales by Region (K Units), 2021–2026
Table 18. Global KRAS G12C Inhibitors Sales Market Share by Region (2021–2026)
Table 19. Global KRAS G12C Inhibitors Sales by Region (K Units), 2027–2032
Table 20. Global KRAS G12C Inhibitors Sales Market Share by Region (2027–2032)
Table 21. Global KRAS G12C Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 22. Global KRAS G12C Inhibitors Revenue Market Share by Region (2021–2026)
Table 23. Global KRAS G12C Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 24. Global KRAS G12C Inhibitors Revenue Market Share by Region (2027–2032)
Table 25. North America KRAS G12C Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America KRAS G12C Inhibitors Sales by Country (K Units), 2021–2026
Table 27. North America KRAS G12C Inhibitors Sales by Country (K Units), 2027–2032
Table 28. North America KRAS G12C Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 29. North America KRAS G12C Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 30. Europe KRAS G12C Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe KRAS G12C Inhibitors Sales by Country (K Units), 2021–2026
Table 32. Europe KRAS G12C Inhibitors Sales by Country (K Units), 2027–2032
Table 33. Europe KRAS G12C Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 34. Europe KRAS G12C Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific KRAS G12C Inhibitors Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific KRAS G12C Inhibitors Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific KRAS G12C Inhibitors Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific KRAS G12C Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific KRAS G12C Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America KRAS G12C Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America KRAS G12C Inhibitors Sales by Country (K Units), 2021–2026
Table 42. Latin America KRAS G12C Inhibitors Sales by Country (K Units), 2027–2032
Table 43. Latin America KRAS G12C Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America KRAS G12C Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa KRAS G12C Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa KRAS G12C Inhibitors Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa KRAS G12C Inhibitors Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa KRAS G12C Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa KRAS G12C Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 50. Global KRAS G12C Inhibitors Sales (K Units) by Type (2021–2026)
Table 51. Global KRAS G12C Inhibitors Sales (K Units) by Type (2027–2032)
Table 52. Global KRAS G12C Inhibitors Sales Market Share by Type (2021–2026)
Table 53. Global KRAS G12C Inhibitors Sales Market Share by Type (2027–2032)
Table 54. Global KRAS G12C Inhibitors Revenue (US$ Million) by Type (2021–2026)
Table 55. Global KRAS G12C Inhibitors Revenue (US$ Million) by Type (2027–2032)
Table 56. Global KRAS G12C Inhibitors Revenue Market Share by Type (2021–2026)
Table 57. Global KRAS G12C Inhibitors Revenue Market Share by Type (2027–2032)
Table 58. Global KRAS G12C Inhibitors Price (US$/Unit) by Type (2021–2026)
Table 59. Global KRAS G12C Inhibitors Price (US$/Unit) by Type (2027–2032)
Table 60. Global KRAS G12C Inhibitors Sales (K Units) by Application (2021–2026)
Table 61. Global KRAS G12C Inhibitors Sales (K Units) by Application (2027–2032)
Table 62. Global KRAS G12C Inhibitors Sales Market Share by Application (2021–2026)
Table 63. Global KRAS G12C Inhibitors Sales Market Share by Application (2027–2032)
Table 64. Global KRAS G12C Inhibitors Revenue (US$ Million) by Application (2021–2026)
Table 65. Global KRAS G12C Inhibitors Revenue (US$ Million) by Application (2027–2032)
Table 66. Global KRAS G12C Inhibitors Revenue Market Share by Application (2021–2026)
Table 67. Global KRAS G12C Inhibitors Revenue Market Share by Application (2027–2032)
Table 68. Global KRAS G12C Inhibitors Price (US$/Unit) by Application (2021–2026)
Table 69. Global KRAS G12C Inhibitors Price (US$/Unit) by Application (2027–2032)
Table 70. Amgen Company Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen KRAS G12C Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Amgen KRAS G12C Inhibitors Product
Table 74. Amgen Recent Developments/Updates
Table 75. Innovent Biologics, Inc. Company Information
Table 76. Innovent Biologics, Inc. Description and Business Overview
Table 77. Innovent Biologics, Inc. KRAS G12C Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Innovent Biologics, Inc. KRAS G12C Inhibitors Product
Table 79. Innovent Biologics, Inc. Recent Developments/Updates
Table 80. Mirati Therapeutics Company Information
Table 81. Mirati Therapeutics Description and Business Overview
Table 82. Mirati Therapeutics KRAS G12C Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Mirati Therapeutics KRAS G12C Inhibitors Product
Table 84. Mirati Therapeutics Recent Developments/Updates
Table 85. Genfleet Therapeutics (Shanghai), Inc. Company Information
Table 86. Genfleet Therapeutics (Shanghai), Inc. Description and Business Overview
Table 87. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product
Table 89. Genfleet Therapeutics (Shanghai), Inc. Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. KRAS G12C Inhibitors Distributors List
Table 93. KRAS G12C Inhibitors Customers List
Table 94. KRAS G12C Inhibitors Market Trends
Table 95. KRAS G12C Inhibitors Market Drivers
Table 96. KRAS G12C Inhibitors Market Challenges
Table 97. KRAS G12C Inhibitors Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of KRAS G12C Inhibitors
Figure 2. Global KRAS G12C Inhibitors Market Value by Type (US$ Million), 2021–2032
Figure 3. Global KRAS G12C Inhibitors Market Share by Type: 2025 & 2032
Figure 4. Garsorasib Product Picture
Figure 5. Fulzerasib Product Picture
Figure 6. Adagrasib Product Picture
Figure 7. Sotorasib Product Picture
Figure 8. Global KRAS G12C Inhibitors Market Value by Application (US$ Million), 2021–2032
Figure 9. Global KRAS G12C Inhibitors Market Share by Application: 2025 & 2032
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global KRAS G12C Inhibitors Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global KRAS G12C Inhibitors Market Size (US$ Million), 2021–2032
Figure 15. Global KRAS G12C Inhibitors Sales (K Units), 2021–2032
Figure 16. Global KRAS G12C Inhibitors Average Price (US$/Unit), 2021–2032
Figure 17. KRAS G12C Inhibitors Report Years Considered
Figure 18. KRAS G12C Inhibitors Sales Share by Manufacturers in 2025
Figure 19. Global KRAS G12C Inhibitors Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global KRAS G12C Inhibitors Players: Market Share by Revenue in KRAS G12C Inhibitors in 2025
Figure 21. KRAS G12C Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global KRAS G12C Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America KRAS G12C Inhibitors Sales Market Share by Country (2021–2032)
Figure 24. North America KRAS G12C Inhibitors Revenue Market Share by Country (2021–2032)
Figure 25. United States KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe KRAS G12C Inhibitors Sales Market Share by Country (2021–2032)
Figure 28. Europe KRAS G12C Inhibitors Revenue Market Share by Country (2021–2032)
Figure 29. Germany KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific KRAS G12C Inhibitors Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific KRAS G12C Inhibitors Revenue Market Share by Region (2021–2032)
Figure 36. China KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America KRAS G12C Inhibitors Sales Market Share by Country (2021–2032)
Figure 44. Latin America KRAS G12C Inhibitors Revenue Market Share by Country (2021–2032)
Figure 45. Mexico KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa KRAS G12C Inhibitors Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa KRAS G12C Inhibitors Revenue Market Share by Country (2021–2032)
Figure 51. Turkey KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE KRAS G12C Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of KRAS G12C Inhibitors by Type (2021–2032)
Figure 55. Global Revenue Market Share of KRAS G12C Inhibitors by Type (2021–2032)
Figure 56. Global KRAS G12C Inhibitors Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of KRAS G12C Inhibitors by Application (2021–2032)
Figure 58. Global Revenue Market Share of KRAS G12C Inhibitors by Application (2021–2032)
Figure 59. Global KRAS G12C Inhibitors Price (US$/Unit) by Application (2021–2032)
Figure 60. KRAS G12C Inhibitors Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
